纤维素:蛋白质,作用机制,分类和应用
Ekaterina A Levicheva1, Daria D Linkova1, Ekaterina A Farafontova1
1Federal State Budgetary Educational Institution of Higher Education, Privolzhsky Research Medical University of the Ministry of Health of the Russian Federation, 603005 Nizhny Novgorod, Russia.
International journal of molecular sciences
|January 10, 2026
概括
纤维素粘合剂对于在手术中停止出血至关重要. 将它们与生物活性物质和细胞疗法结合起来,提高了它们的有效性,从而产生了新的,改进的配方.
科学领域:
- 生物材料科学 生物材料科学
- 手术创新 在外科创新.
- 血液静止研究 血液静止研究
背景情况:
- 纤维素是一种具有粘附性质的生物相容血静剂.
- 在外科手术中广泛使用,它们独立或与机械方法一起有效,特别是在具有挑战性的解剖位置.
研究的目的:
- 审查当前和正在开发的纤维素,它们的机制和特性.
- 为了突出纤维素在与生物活性物质 (BAS) 和细胞疗法相结合时的增强疗效.
- 讨论下一代纤维素粘合剂的开发,其配方优化,性能可调.
主要方法:
- 审查关于纤维素应用和开发的现有文献.
- 对实验数据的分析证明了纤维素粘合剂与BASs的疗效.
- 检查正在进行的纤维素结细胞和组织相互作用的研究.
主要成果:
- 纤维素粘合剂具有出色的止血和粘合性能,对于伤口关闭和外科干预至关重要.
- 实验模型显示,当与抗生素和生长因子等BAS相结合时,纤维素的疗效增加.
- 新的纤维素配方正在开发中,以长期使用和可调节性质.
结论:
- 纤维素是不可或缺的手术工具,通过组合疗法具有显著的增强潜力.
- 对纤维素粘合剂相互作用和配方优化的持续研究有望提供先进的静血解决方案.
- 预计将开发出新一代具有可调节特性的纤维素粘合剂.
相关概念视频
Clot Retraction and Fibrinolysis
8.4K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
8.4K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
1.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.6K
Fibronectins Connect Cells with ECM
3.3K
Fibronectin is an adhesive glycoprotein present in the extracellular matrix of embryogenic and adult tissue. These molecules primarily aid in regulating cell motility and attachment. A fibronectin molecule is composed of two identical polypeptide chains attached to each other by a pair of disulfide bonds at the C-terminal.
Both proteoglycans and collagen are attached to fibronectin proteins, which, in turn, are attached to integrin proteins. These integrin proteins interact with transmembrane...
Both proteoglycans and collagen are attached to fibronectin proteins, which, in turn, are attached to integrin proteins. These integrin proteins interact with transmembrane...
3.3K
Coagulation
9.6K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
9.6K
Fibrous Proteins
4.1K
Fibrous proteins are either long and narrow proteins or assemble to form long and thin structures. They contain repetitive units and usually consist of either alpha helices or beta sheets and, in rare cases, a mix of both. The amino acids in the primary structure often consist of repeating amino acid sequences. The role of fibrous proteins is primarily structural. Many are located in the extracellular matrix and are present in connective tissues to impart strength and joint mobility. They are...
4.1K
Extrinsic and Intrinsic Pathways of Hemostasis
12.0K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
12.0K


